KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) EPS (Weighted Average and Diluted): 2019-2024

Historic EPS (Weighted Average and Diluted) for Moderna (MRNA) over the last 6 years, with Dec 2024 value amounting to -$9.28.

  • Moderna's EPS (Weighted Average and Diluted) fell 1800.00% to -$0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.07, marking a year-over-year decrease of 38.90%. This contributed to the annual value of -$9.28 for FY2024, which is 24.74% up from last year.
  • Per Moderna's latest filing, its EPS (Weighted Average and Diluted) stood at -$9.28 for FY2024, which was up 24.74% from -$12.33 recorded in FY2023.
  • In the past 5 years, Moderna's EPS (Weighted Average and Diluted) ranged from a high of $28.29 in FY2021 and a low of -$12.33 during FY2023.
  • Over the past 3 years, Moderna's median EPS (Weighted Average and Diluted) value was -$9.28 (recorded in 2024), while the average stood at -$0.50.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first surged by 1,543.37% in 2021, then plummeted by 161.28% in 2023.
  • Moderna's EPS (Weighted Average and Diluted) (Yearly) stood at -$1.96 in 2020, then spiked by 1,543.37% to $28.29 in 2021, then fell by 28.88% to $20.12 in 2022, then crashed by 161.28% to -$12.33 in 2023, then rose by 24.74% to -$9.28 in 2024.